Tahir Amin of I-MAK speaks to IP-Watch about Natco’s attempt to obtain a compulsory licence for exporting two cancer drugs to Nepal and the concerns surrounding the Indian patent office’s procedure.
Learn more about how you can help build a more equitable system for all Notice: JavaScript is required for this content.